This study was done to assess whether self monitoring of blood glucose is associated with better glycaemic control in type 2 diabetic Trinidadians. Data was collected from 146 type 2 diabetics via interviews and medic...This study was done to assess whether self monitoring of blood glucose is associated with better glycaemic control in type 2 diabetic Trinidadians. Data was collected from 146 type 2 diabetics via interviews and medical files. Variables extracted included fasting blood glucose, HbA1c and lipid profile. Recent users of the glucometer had better glycemic control compared with longstanding users (HbA1c: 8.4% ± 0.28% vs 9.4% ± 0.62%). Diabetics using a glucometer for >11 years had the highest cholesterol (234 ± 27mg/dL) while those using it 6 months to 5 yrs had the lowest values (206 ± 8 mg/dL). Using the glucometer occasionally or once a week had little impact on these indices. Usage of insulin preparation was positively correlated with HbA1c (r = 0.295;p = 0.001) while those relying on oral hypoglycaemic agents showed a negative correlation (r = -0.265). Further, those who took their medication as prescribed had a lower HbA1c than those who took their medication occasionally. Ironically, HbA1c fell with increasing duration between clinic visits with those visiting annually having the lowest HbA1c (9.0% ± 0.2% vs 7.1% ± 0.7%). Compliance with lifestyle and exercise resulted in lower HbA1c and blood lipids. Poor client education on glucometer usage, administration of insulin and non-compliance with diet and exercise were associated with higher HbA1c.展开更多
In recent decades, due to the increasing risk of diabetes, the measurement and control of the blood sugar is of great importance. In typeI diabetes, because of the lack of insulin secretion, the cells cannot absorb gl...In recent decades, due to the increasing risk of diabetes, the measurement and control of the blood sugar is of great importance. In typeI diabetes, because of the lack of insulin secretion, the cells cannot absorb glucose, and thus have a low level of glucose. To control blood glucose, the insulin must be injected to the body. In fact, the injection must be in a completely controlled environment. If the level of the insulin exceeds the physiological limits, it may cause death. This paper presents an online approach to control the blood glucose level using a nonlinear model predictive control. This method, maintains the level of blood glucose concentration within a normal range. Thus, the blood glucose level is measured in each minute and predicted for the next time interval. If that is not in the normal range, amount of the insulin which must be injected will be determined. The proposed control approach includes important features such as model uncertainties and prevents acute decrease in the blood glucose level, and instability. In order to assess performance of the proposed controller, computer simulations have been carried out in Matlab/Simulink. Simulation results will reveal the effectiveness of the proposed nonlinear model predictive controller in adjusting the blood glucose level by injecting required insulin. So if the nutrition of the person decreases instantly, the hypoglycemia does not happen.展开更多
目的:探讨德谷胰岛素利拉鲁肽治疗血糖控制不佳的肥胖2型糖尿病的效果。方法:选择2021年8月至2023年5月该院收治的血糖控制不佳的肥胖2型糖尿病患者84例,采用随机数字表法分为观察组42例、对照组42例。对照组患者采用甘精胰岛素注射液...目的:探讨德谷胰岛素利拉鲁肽治疗血糖控制不佳的肥胖2型糖尿病的效果。方法:选择2021年8月至2023年5月该院收治的血糖控制不佳的肥胖2型糖尿病患者84例,采用随机数字表法分为观察组42例、对照组42例。对照组患者采用甘精胰岛素注射液联合沙格列汀片治疗,观察组患者采用德谷胰岛素利拉鲁肽注射液联合沙格列汀片治疗,两组患者均治疗12周。比较两组患者的临床疗效和不良反应发生情况,血糖达标率、体重指数、糖化血红蛋白、空腹血清C肽(FCP)、血清2 h C肽(2 hPCP)、空腹血糖、空腹胰岛素水平及胰岛素抵抗指数。结果:治疗后,观察组患者的总有效率为90.48%(38/42),高于对照组的71.43%(30/42),差异有统计学意义(P<0.05)。观察组患者治疗6、12周后,血糖达标率高于对照组,差异均有统计学意义(P<0.05)。治疗后,观察组患者的体重指数、空腹血糖水平和胰岛素抵抗指数低于对照组,FCP、2 hPCP和空腹胰岛素水平高于对照组,差异均有统计学意义(P<0.05);两组患者糖化血红蛋白水平的差异无统计学意义(P>0.05)。两组患者低血压发生率、不良反应发生率的差异均无统计学意义(P>0.05)。结论:德谷胰岛素利拉鲁肽能够有效改善血糖控制不佳的肥胖2型糖尿病患者的血糖水平,提高临床疗效,降低患者体重指数及胰岛素抵抗指数,不良反应少。展开更多
目的探讨马来酸依那普利叶酸片与硝苯地平控释片联合应用于H型高血压患者中的效果。方法选取2020年6月至2021年6月滕州市中医医院收治的94例H型高血压患者作为研究对象,按照随机数字表法分为两组,各47例。对照组应用硝苯地平控释片治疗...目的探讨马来酸依那普利叶酸片与硝苯地平控释片联合应用于H型高血压患者中的效果。方法选取2020年6月至2021年6月滕州市中医医院收治的94例H型高血压患者作为研究对象,按照随机数字表法分为两组,各47例。对照组应用硝苯地平控释片治疗,观察组在对照组基础上加用马来酸依那普利叶酸片治疗,比较两组临床疗效、糖脂代谢水平、血压控制效果、血浆高同型半胱氨酸(HCY)水平及不良反应发生率。结果观察组治疗总有效率为95.74%,高于对照组的82.98%,差异有统计学意义(P<0.05)。治疗后,两组空腹血糖(FBG)、餐后2 h血糖(2 h PBG)、糖化血红蛋白A1c(HbAlc)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)及总胆固醇(TC)水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);治疗后,两组收缩压、舒张压均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);治疗后,两组血浆HCY水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。两组不良反应发生率比较差异无统计学意义。结论马来酸依那普利叶酸片联合硝苯地平控释片治疗H型高血压患者疗效显著,有利于改善患者糖脂代谢,降低血压与HCY水平,且不会增加不良反应的发生,安全性较高,值得临床推广应用。展开更多
目的探究预见性血糖控制在重症糖尿病患者中的应用价值。方法选取泉州市第一医院于2023年1—11月收治的90例重症糖尿病患者为研究对象,采用密闭信封法分为对照组和研究组,各45例。对照组实施常规血糖控制,研究组行预见性血糖控制。于干...目的探究预见性血糖控制在重症糖尿病患者中的应用价值。方法选取泉州市第一医院于2023年1—11月收治的90例重症糖尿病患者为研究对象,采用密闭信封法分为对照组和研究组,各45例。对照组实施常规血糖控制,研究组行预见性血糖控制。于干预前及干预2个月后,检测两组空腹血糖(Fasting Plasma Glucose,FPG)、餐后2 h血糖(2-hour Postprandial Blood Glucose,2 hPG)水平,采用微型营养评价量表(Mini Nutritional Assessment Form,MNA)评价两组营养状况,采用生活质量简表(World Health Organization on Quality of Life Scale-100,WHOQOL-100)评价两组生活质量。结果干预2个月后,研究组FPG水平为(5.35±0.78)mmol/L,2 hPG水平为(7.29±0.61)mmol/L,均低于对照组,差异有统计学意义(t=9.674、21.104,P均<0.05)。研究组MNA、WHOQOL-100得分高于对照组,差异有统计学意义(P均<0.05)。结论重症糖尿病患者应用预见性血糖控制,可有效降低血糖水平,并提高营养状态及生活质量。展开更多
文摘This study was done to assess whether self monitoring of blood glucose is associated with better glycaemic control in type 2 diabetic Trinidadians. Data was collected from 146 type 2 diabetics via interviews and medical files. Variables extracted included fasting blood glucose, HbA1c and lipid profile. Recent users of the glucometer had better glycemic control compared with longstanding users (HbA1c: 8.4% ± 0.28% vs 9.4% ± 0.62%). Diabetics using a glucometer for >11 years had the highest cholesterol (234 ± 27mg/dL) while those using it 6 months to 5 yrs had the lowest values (206 ± 8 mg/dL). Using the glucometer occasionally or once a week had little impact on these indices. Usage of insulin preparation was positively correlated with HbA1c (r = 0.295;p = 0.001) while those relying on oral hypoglycaemic agents showed a negative correlation (r = -0.265). Further, those who took their medication as prescribed had a lower HbA1c than those who took their medication occasionally. Ironically, HbA1c fell with increasing duration between clinic visits with those visiting annually having the lowest HbA1c (9.0% ± 0.2% vs 7.1% ± 0.7%). Compliance with lifestyle and exercise resulted in lower HbA1c and blood lipids. Poor client education on glucometer usage, administration of insulin and non-compliance with diet and exercise were associated with higher HbA1c.
文摘In recent decades, due to the increasing risk of diabetes, the measurement and control of the blood sugar is of great importance. In typeI diabetes, because of the lack of insulin secretion, the cells cannot absorb glucose, and thus have a low level of glucose. To control blood glucose, the insulin must be injected to the body. In fact, the injection must be in a completely controlled environment. If the level of the insulin exceeds the physiological limits, it may cause death. This paper presents an online approach to control the blood glucose level using a nonlinear model predictive control. This method, maintains the level of blood glucose concentration within a normal range. Thus, the blood glucose level is measured in each minute and predicted for the next time interval. If that is not in the normal range, amount of the insulin which must be injected will be determined. The proposed control approach includes important features such as model uncertainties and prevents acute decrease in the blood glucose level, and instability. In order to assess performance of the proposed controller, computer simulations have been carried out in Matlab/Simulink. Simulation results will reveal the effectiveness of the proposed nonlinear model predictive controller in adjusting the blood glucose level by injecting required insulin. So if the nutrition of the person decreases instantly, the hypoglycemia does not happen.
文摘目的:探讨德谷胰岛素利拉鲁肽治疗血糖控制不佳的肥胖2型糖尿病的效果。方法:选择2021年8月至2023年5月该院收治的血糖控制不佳的肥胖2型糖尿病患者84例,采用随机数字表法分为观察组42例、对照组42例。对照组患者采用甘精胰岛素注射液联合沙格列汀片治疗,观察组患者采用德谷胰岛素利拉鲁肽注射液联合沙格列汀片治疗,两组患者均治疗12周。比较两组患者的临床疗效和不良反应发生情况,血糖达标率、体重指数、糖化血红蛋白、空腹血清C肽(FCP)、血清2 h C肽(2 hPCP)、空腹血糖、空腹胰岛素水平及胰岛素抵抗指数。结果:治疗后,观察组患者的总有效率为90.48%(38/42),高于对照组的71.43%(30/42),差异有统计学意义(P<0.05)。观察组患者治疗6、12周后,血糖达标率高于对照组,差异均有统计学意义(P<0.05)。治疗后,观察组患者的体重指数、空腹血糖水平和胰岛素抵抗指数低于对照组,FCP、2 hPCP和空腹胰岛素水平高于对照组,差异均有统计学意义(P<0.05);两组患者糖化血红蛋白水平的差异无统计学意义(P>0.05)。两组患者低血压发生率、不良反应发生率的差异均无统计学意义(P>0.05)。结论:德谷胰岛素利拉鲁肽能够有效改善血糖控制不佳的肥胖2型糖尿病患者的血糖水平,提高临床疗效,降低患者体重指数及胰岛素抵抗指数,不良反应少。
文摘目的探讨马来酸依那普利叶酸片与硝苯地平控释片联合应用于H型高血压患者中的效果。方法选取2020年6月至2021年6月滕州市中医医院收治的94例H型高血压患者作为研究对象,按照随机数字表法分为两组,各47例。对照组应用硝苯地平控释片治疗,观察组在对照组基础上加用马来酸依那普利叶酸片治疗,比较两组临床疗效、糖脂代谢水平、血压控制效果、血浆高同型半胱氨酸(HCY)水平及不良反应发生率。结果观察组治疗总有效率为95.74%,高于对照组的82.98%,差异有统计学意义(P<0.05)。治疗后,两组空腹血糖(FBG)、餐后2 h血糖(2 h PBG)、糖化血红蛋白A1c(HbAlc)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)及总胆固醇(TC)水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);治疗后,两组收缩压、舒张压均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05);治疗后,两组血浆HCY水平均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。两组不良反应发生率比较差异无统计学意义。结论马来酸依那普利叶酸片联合硝苯地平控释片治疗H型高血压患者疗效显著,有利于改善患者糖脂代谢,降低血压与HCY水平,且不会增加不良反应的发生,安全性较高,值得临床推广应用。
文摘目的探究预见性血糖控制在重症糖尿病患者中的应用价值。方法选取泉州市第一医院于2023年1—11月收治的90例重症糖尿病患者为研究对象,采用密闭信封法分为对照组和研究组,各45例。对照组实施常规血糖控制,研究组行预见性血糖控制。于干预前及干预2个月后,检测两组空腹血糖(Fasting Plasma Glucose,FPG)、餐后2 h血糖(2-hour Postprandial Blood Glucose,2 hPG)水平,采用微型营养评价量表(Mini Nutritional Assessment Form,MNA)评价两组营养状况,采用生活质量简表(World Health Organization on Quality of Life Scale-100,WHOQOL-100)评价两组生活质量。结果干预2个月后,研究组FPG水平为(5.35±0.78)mmol/L,2 hPG水平为(7.29±0.61)mmol/L,均低于对照组,差异有统计学意义(t=9.674、21.104,P均<0.05)。研究组MNA、WHOQOL-100得分高于对照组,差异有统计学意义(P均<0.05)。结论重症糖尿病患者应用预见性血糖控制,可有效降低血糖水平,并提高营养状态及生活质量。
